You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK – Natera said after the close of the market on Thursday that on March 8, it terminated its license, development, and distribution agreement with Qiagen to develop and distribute next-gen sequencing-based genetic tests.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.